HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
人岩藻糖基转移酶结构/功能分析
基本信息
- 批准号:2871891
- 负责人:
- 金额:$ 33.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-02-15 至 2002-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (adapted from the investigator's abstract) Expression of
carbohydrate structures at the cell surface has been found to play an
important role in many cellular processes, eg. cell-cell recognition,
growth control, and receptor binding. Carbohydrates containing an
a1A3-linked fucose on lacto- and neolacto-series core chains are found to be
tumor-associated markers in many human cancers. Enzymes capable of
catalyzing transfer of fucose into these acceptors have been identified and
studied. Presently, at least six distinct a1A3 fucosyltransferases have
been identified from human sources. Five of these enzymes have been cloned
and their DNA and amino acid sequences determined. These enzymes are
characterized by differences in enzymatic properties including acceptor
specificity, kinetic properties, and distributions. This family of enzymes
is an ideal system for studies of structure function relationships of
glycosyltransferases. The research proposed in this application will take
advantage of the multiplicity of enzyme forms and properties to identify
specific residues and portions of the enzyme involved in substrate binding
and catalysis. The initial focus will be on identifying by chemical means
specific residues which have previously been determined to be essential for
activity based upon results from site-specific chemical reagents. Examples
include the GDP-frucose protected, N-ethylmaleamide-sensitive Cys residue
present in eg. FT-III and -V and the GDP-fucose protected pyridoxal-P
modifiable Lys residue present in each enzyme form. Other studies will use
photoaffinity reagents to probe the binding sites for acceptor carbohydrates
and donor GDP-fucose and analysis of acceptor binding properties through
domain swapped variants. Site-directed mutagenesis and enzyme kinetic
studies will be used to analyze the function of these sites in substrate
binding and catalysis. These studies will provide information leading to a
better understanding of enzyme function and, perhaps, a basis for
differences in acceptor specificity. Another aim will focus on cloning and
genetic characterization of a novel fucosyltransferase enzyme from NCI-H69
small cell lung carcinoma cells. This enzyme has properties distinct from
other known forms.
The research proposed in this application will lead to a greater
understanding of enzyme complexity, structure-function relationships, and
the nature of active sites in this family of enzymes having important
function in disease processes.
描述:(改编自研究者的摘要)表达
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric Holmes其他文献
Eric Holmes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric Holmes', 18)}}的其他基金
INBRE II: Hawaii Statewide Research & Education Partnership (HSREP)
INBRE II:夏威夷全州研究
- 批准号:
8137032 - 财政年份:2001
- 资助金额:
$ 33.68万 - 项目类别:
Cellular Basis of Immunological and Neurological Disease
免疫和神经疾病的细胞基础
- 批准号:
7471544 - 财政年份:2001
- 资助金额:
$ 33.68万 - 项目类别:
INBRE II: Hawaii Statewide Research & Education Partnership (HSREP)
INBRE II:夏威夷全州研究
- 批准号:
8288745 - 财政年份:2001
- 资助金额:
$ 33.68万 - 项目类别:
INBRE II: Hawaii Statewide Research & Education Partnership (HSREP)
INBRE II:夏威夷全州研究
- 批准号:
7900700 - 财政年份:2001
- 资助金额:
$ 33.68万 - 项目类别:
ANTIBODY TARGETING TO PSMA IN PROSTATIC TUMORS
前列腺肿瘤中针对 PSMA 的抗体
- 批准号:
2776431 - 财政年份:1999
- 资助金额:
$ 33.68万 - 项目类别:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
人岩藻糖基转移酶结构/功能分析
- 批准号:
6350191 - 财政年份:1997
- 资助金额:
$ 33.68万 - 项目类别:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
人岩藻糖基转移酶结构/功能分析
- 批准号:
2654220 - 财政年份:1997
- 资助金额:
$ 33.68万 - 项目类别:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
人岩藻糖基转移酶结构/功能分析
- 批准号:
2009747 - 财政年份:1997
- 资助金额:
$ 33.68万 - 项目类别:
HUMAN FUCOSYLTRANSFERASE STRUCTURE/FUNCTION ANALYSIS
人岩藻糖基转移酶结构/功能分析
- 批准号:
6150220 - 财政年份:1997
- 资助金额:
$ 33.68万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 33.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 33.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 33.68万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 33.68万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 33.68万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 33.68万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 33.68万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 33.68万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 33.68万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 33.68万 - 项目类别:
Studentship